A multicenter, randomized, double-blind, placebo-controlled, parallel group, one-year study of the efficacy and safety of topiramate in the treatment of obese subjects with dyslipidemia.
Phase of Trial: Phase III
Latest Information Update: 03 May 2010
At a glance
- Drugs Topiramate (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 23 Jun 2009 Actual patient number (21) added as reported by ClinicalTrials.gov.
- 23 Jun 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 05 Nov 2005 New trial record.